fda bpc-157 not approved for human use Understanding the Legal Risks of and Other Unapproved Peptides – Holt Law bpc-157 fda approval status safety
Description
If so I apologize
doi: 10.1016/j.cmet.2011.08.014

(2013) The erythropoietinanalogue ARA 290 for treatment of sarcoidosis-induced chronic neuropathic pain

If they are not, they become unpredictable, because they act throughout the body

Comprehensive Clinical Trial Program: Approximately 900 participants were enrolled across six Phase II clinical trials evaluating AOD-9604 for obesity treatment